Join our Newsletter
From medical white papers to invite only networking, join our newsletter to stay connected with the world of CRC.
Neurology
The CRO
for Neurology
Neurology trials are among the most complex in clinical research. Subtle changes in cognition or motor function must be captured with accuracy. Progressive diseases demand long-term engagement from patients, sites, and study teams. And with limited specialized neurology investigative sites, execution relies on trust built over decades.
For two decades, CRC has focused exclusively on neuroscience – supporting over 60 neurology clinical trials across Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, and rare neurological conditions. Sponsors choose CRC as their neurology CRO partner because of our clarity, continuity, and scientific rigor needed to move programs forward with confidence.
- Age Associated Memory Impairment
- Agitation – Dementia & Alzheimer’s
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Ataxia
- Cognition
- Epilepsy
- Multiple System Atrophy
- Parkinson’s Disease
- Sleep Disorders
HOW CRC DELIVERS IN
NEUROLOGY TRIALS
Embedded Assessments Expertise That Safeguards Neurology Data
Subtle changes in cognition or motor function can make or break a neurology trial. CRC’s in-house assessments team has spent decades ensuring reliability across measures like ADAS-Cog, MoCA, UPDRS, and EDSS. With tailored training, simulation-based certification, and ongoing drift monitoring, our team delivers cleaner data and clearer signals that stand up to regulatory review.
Teams That Stay The Course In Long-Duration Trials
Neurology studies often span years, and turnover can derail momentum. CRC’s employee retention rate of more than 86 percent means sponsors work with teams who remain with programs from start-up to closeout. That consistency preserves knowledge, avoids costly handoffs, and keeps progress steady across the life of the study.
Scientific Leadership With Real Neurology Experience
Our medical and scientific leaders have advanced neurology therapies from first-in-human through FDA approval. With expertise in Alzheimer’s, Parkinson’s, epilepsy, and rare neurological disorder clinical development, they know how to design protocols that are both feasible and clinically meaningful, guiding programs with the insight only hands-on experience provides.
Site Partnerships That Unlock Hard-to-Reach Populations
Experienced neurology sites and investigators are scarce, and recruiting patients can be especially challenging in progressive or rare conditions. CRC’s long-standing partnerships with 300+ sites and leading KOLs help sponsors access the right patients faster, anticipate site-level challenges early, and sustain engagement throughout demanding neurology trials.
Proven Impact in
Neurology Clinical Development
The proof is in our partnerships. 87% of our sponsors return for new collaborations – a reflection of the trust we build and the results we deliver.
get in touch